Venkataraman Balasubramanian

Array ( [id] => 6801635 [patent_doc_number] => 20030096800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Estrogenic compounds as anti-mitotic agents' [patent_app_type] => new [patent_app_number] => 10/280831 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3466 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096800.pdf [firstpage_image] =>[orig_patent_app_number] => 10280831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7616988 [patent_doc_number] => 06946453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => '4-dedimethylaminotracycline derivatives' [patent_app_type] => utility [patent_app_number] => 10/274841 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 18646 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946453.pdf [firstpage_image] =>[orig_patent_app_number] => 10274841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760723 [patent_doc_number] => 20030124084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin' [patent_app_type] => new [patent_app_number] => 10/169101 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2725 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124084.pdf [firstpage_image] =>[orig_patent_app_number] => 10169101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823724 [patent_doc_number] => 07405206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Anti-inflammatory androstane derivatives' [patent_app_type] => utility [patent_app_number] => 10/492813 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14918 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405206.pdf [firstpage_image] =>[orig_patent_app_number] => 10492813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660177 [patent_doc_number] => 20030134821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Promoters of neural regeneration' [patent_app_type] => new [patent_app_number] => 10/272774 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6522 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134821.pdf [firstpage_image] =>[orig_patent_app_number] => 10272774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711596 [patent_doc_number] => 20030171345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => '8Beta-substituted 11beta-aryl-estra-1,3,5,(10)-triene derivatives' [patent_app_type] => new [patent_app_number] => 10/270077 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11895 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171345.pdf [firstpage_image] =>[orig_patent_app_number] => 10270077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711827 [patent_doc_number] => 20030171576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols' [patent_app_type] => new [patent_app_number] => 10/268660 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6217 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171576.pdf [firstpage_image] =>[orig_patent_app_number] => 10268660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856744 [patent_doc_number] => 20030130245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Stabilized aqueous suspensions for parenteral use' [patent_app_type] => new [patent_app_number] => 10/267690 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5998 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130245.pdf [firstpage_image] =>[orig_patent_app_number] => 10267690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224986 [patent_doc_number] => 20040072812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Process for isolating conjugated estrogens' [patent_app_type] => new [patent_app_number] => 10/266754 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8643 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 266 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072812.pdf [firstpage_image] =>[orig_patent_app_number] => 10266754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660184 [patent_doc_number] => 20030134828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Composition and method for increasing in vivo androgen concentration' [patent_app_type] => new [patent_app_number] => 10/265218 [patent_app_country] => US [patent_app_date] => 2002-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11117 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134828.pdf [firstpage_image] =>[orig_patent_app_number] => 10265218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818257 [patent_doc_number] => 20030069215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate' [patent_app_type] => new [patent_app_number] => 10/260854 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11651 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069215.pdf [firstpage_image] =>[orig_patent_app_number] => 10260854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826912 [patent_doc_number] => 07402577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Androstane 17-beta-carboxamides as androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/491403 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20731 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402577.pdf [firstpage_image] =>[orig_patent_app_number] => 10491403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953992 [patent_doc_number] => 06958406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-25 [patent_title] => 'Colorant compounds' [patent_app_type] => utility [patent_app_number] => 10/260146 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24715 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958406.pdf [firstpage_image] =>[orig_patent_app_number] => 10260146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721339 [patent_doc_number] => 20030055029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'COMBBRETASTATIN A-4 AS AN ANTI-ANGIOGENIC AGENT' [patent_app_type] => new [patent_app_number] => 10/255652 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3466 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055029.pdf [firstpage_image] =>[orig_patent_app_number] => 10255652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1170879 [patent_doc_number] => 06753435 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-22 [patent_title] => 'Intermediates for vitamin D and processes for the preparation thereof' [patent_app_type] => B1 [patent_app_number] => 10/239778 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5125 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753435.pdf [firstpage_image] =>[orig_patent_app_number] => 10239778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276674 [patent_doc_number] => 20040236125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Novel structures and compositions comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease, its underlying conditions including hyperlipidemia and other disorders having inflammation as part of their aetiology or presentation' [patent_app_type] => new [patent_app_number] => 10/255558 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7757 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20040236125.pdf [firstpage_image] =>[orig_patent_app_number] => 10255558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972287 [patent_doc_number] => 20050037997 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-02-17 [patent_title] => 'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis' [patent_app_type] => utility [patent_app_number] => 10/251522 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 23659 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0037/20050037997.pdf [firstpage_image] =>[orig_patent_app_number] => 10251522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972287 [patent_doc_number] => 20050037997 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-02-17 [patent_title] => 'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis' [patent_app_type] => utility [patent_app_number] => 10/251522 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 23659 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0037/20050037997.pdf [firstpage_image] =>[orig_patent_app_number] => 10251522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814124 [patent_doc_number] => 20030073674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers' [patent_app_type] => new [patent_app_number] => 10/245775 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5649 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073674.pdf [firstpage_image] =>[orig_patent_app_number] => 10245775 [rel_patent_id] =>[rel_patent_doc_number] =>)